Stock Price
3.22
Daily Change
-0.07 -2.13%
Monthly
-13.21%
Yearly
50.47%
Q2 Forecast
3.15

EDAP TMS reported EUR18.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AngioDynamics USD 81.95M 1.68M Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
EDAP TMS EUR 18.8M 3.01M Sep/2025
Henry Schein USD 3.25B 110M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Veracyte USD 116M 7.24M Dec/2025